Defending $300k/Year Orphan Drug Pricing to National Health Ministries
Health ministries resist high-cost rare disease treatments. Discover how market access directors prove Quality-Adjusted Life Years (QALY) and offset hospitalization costs.
Amit KasliwalCEO & Founder, Dehurdle
March 14, 20234 min read
The Health Economics Offset Defense
Recommended Spoken Script
"While the annual therapy cost is €280,000, this one-time precision enzyme replacement eliminates the €450,000 in annual emergency ICU hospitalizations and permanent organ damage previously suffered by each patient, generating a net lifetime saving of €1.2M per treated individual for the national health budget."
The 2-Minute Practice Drill
2-Minute Spoken Drill
The 2-Minute Practice Drill
Practice orphan drug reimbursement negotiations in Dehurdle.